Using data on SMARCA4 mutations in 18 types of tumors obtained from TCGA through cBioPortal48, we found SMARCA4 to be mutated in either none or up to 8.5% of the samples, depending on the tumor type. Here, SMARCA4 is linked to neoplasm.